![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Website
Recent investment activity
KANDO id: 39905
Corporate information
Registration country
Funding rounds
Investment preferences
Actual initial investment stage
Series A (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 10 of 10| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Affimed Therapeutics AG | Antibody therapeutics for cancer and inflammatory diseases. | Series C | |||
|
|
Crescendo Bioscience Inc | Series C | ||||
|
|
Tethys Bioscience Inc | Series D | ||||
|
|
Adamas Pharmaceuticals Inc | Series D | ||||
|
|
Attensity Group Inc | Developer of text analytics software | N/A | |||
|
Glam Media Inc | Female-focused online advertising network | N/A | |||
|
Livescribe Inc | Series D USD 7,500,000 (USD 7,500,000) | ||||
|
Nanosolar Inc | Printed thin-film photovoltaics. | N/A | |||
|
|
Smaato | Provider of mobile advertising platform technology | Series A Initial investment | |||
|
SynapSense Corp | A leading provider of energy efficiency-focused data center infrastructure management (DCIM) solutions. | N/A |